Find clinical documentation and medical coding guidance for Coronary Disease Status Post Stent Placement, also known as Post-PCI Coronary Disease, Coronary Artery Disease with Stent, or Coronary Stent Status. This resource offers information on diagnosis codes, healthcare best practices, and proper terminology for Coronary Artery Disease with Stent for accurate clinical documentation and coding compliance. Learn about post-PCI care and management of Coronary Stent Status.
Also known as
Atherosclerosis of coronary artery bypass graft(s) with unstable angina
Indicates coronary artery disease after bypass surgery with unstable angina.
Presence of coronary artery bypass graft(s)
Identifies the presence of a coronary artery bypass graft.
Atherosclerosis of native coronary artery with unstable angina
Specifies atherosclerosis in a native coronary artery with unstable angina.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the coronary artery disease native or due to CABG?
Native
Is there angina?
CABG
Is there angina?
When to use each related code
| Description |
|---|
| Coronary artery disease treated with stent placement. |
| Coronary artery disease without stent placement. |
| Angina pectoris. |
Missing documentation of stent placement side (right, left, or both) can lead to inaccurate coding and reimbursement.
Lack of detail about the specific coronary artery treated may result in undercoding or overcoding the procedure.
Conflicting documentation of acute coronary syndrome versus chronic CAD status post stent can impact DRG assignment.
Q: What are the best evidence-based strategies for managing dual antiplatelet therapy (DAPT) after coronary stent placement in patients with complex coronary artery disease?
A: Managing DAPT duration in patients with complex coronary artery disease after stent placement requires careful consideration of ischemic and bleeding risks. Current guidelines recommend a minimum DAPT duration of 12 months in most patients, with potential extension beyond 12 months in those at high ischemic risk and low bleeding risk. Factors such as stent type (drug-eluting stent vs. bare-metal stent), clinical presentation (acute coronary syndrome vs. stable angina), comorbidities (diabetes, prior myocardial infarction), and bleeding risk factors should all inform the DAPT duration decision. For patients at very high bleeding risk, a shorter DAPT duration (e.g., 1-3 months) followed by single antiplatelet therapy may be considered. Individualized assessment is crucial, and shared decision-making with the patient is essential. Explore how risk stratification tools can aid in optimizing DAPT duration and minimizing adverse events. Consider implementing a standardized protocol for DAPT management in your practice to ensure consistent, evidence-based care.
Q: How can clinicians differentiate in-stent restenosis from stent thrombosis in a patient presenting with chest pain after coronary stent placement?
A: Differentiating in-stent restenosis from stent thrombosis in a patient with chest pain after PCI can be challenging but is crucial due to the different management implications. In-stent restenosis typically presents with recurrent angina, often weeks to months after the procedure, and is usually diagnosed with coronary angiography, demonstrating focal narrowing within the stented segment. Stent thrombosis, on the other hand, is a more acute and potentially life-threatening event presenting with sudden onset chest pain, often within days to weeks (early stent thrombosis) or months to years (late stent thrombosis) after the procedure. ECG changes consistent with acute myocardial infarction and elevated cardiac biomarkers further support the diagnosis of stent thrombosis. Urgent coronary angiography is often necessary for diagnosis and management. Clinical features, timing of symptom onset, and ECG and biomarker findings can guide the initial assessment, but angiography remains the gold standard for definitive diagnosis. Learn more about the latest imaging modalities and their role in distinguishing these two critical post-PCI complications.
Patient presents with a history of coronary artery disease status post stent placement. The patient's past medical history includes percutaneous coronary intervention (PCI) with drug-eluting stent implantation in the [specify artery, e.g., left anterior descending artery] due to [specify reason, e.g., stable angina, acute coronary syndrome]. Current symptoms include [document current symptoms, e.g., chest pain, shortness of breath, or asymptomatic]. Physical examination reveals [document relevant findings, e.g., regular heart rate and rhythm, clear lung sounds, or presence of abnormal heart sounds]. Electrocardiogram (ECG) shows [describe ECG findings, e.g., normal sinus rhythm, no ST-segment changes, or evidence of prior myocardial infarction]. Current medications include [list medications, e.g., aspirin, clopidogrel, statin, beta-blocker, ACE inhibitor]. Assessment: Coronary artery disease status post stent placement, stable angina (or other appropriate diagnosis based on current symptoms). Plan: Continue current medical therapy. Patient education provided regarding medication compliance, lifestyle modifications including diet and exercise, and the importance of follow-up appointments. Scheduled for follow-up stress test (or other appropriate diagnostic test) in [specify timeframe] to assess stent patency and myocardial perfusion. Diagnosis codes: [include relevant ICD-10 codes, e.g., I25.10, Z98.61]. Procedure codes: [include relevant CPT codes for any procedures performed, e.g., 93010 for ECG]. Return to clinic in [specify timeframe] for ongoing management of coronary artery disease.